• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板-血红蛋白比值预测膝下外周动脉疾病患者的截肢。

Platelet-hemoglobin ratio predicts amputation in patients with below-knee peripheral arterial disease.

机构信息

Department of Cardiology Clinic, Pursaklar State Hospital, 39 Cagatay Street, Pursaklar, Mimar Sinan District, 06145, Ankara, Turkey.

Diskapi Yildirim Beyazit Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

出版信息

BMC Cardiovasc Disord. 2022 Jul 28;22(1):337. doi: 10.1186/s12872-022-02788-2.

DOI:10.1186/s12872-022-02788-2
PMID:35902808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9336049/
Abstract

BACKGROUND

Peripheral arterial disease (PAD) causes significant morbidity today. Atherosclerosis is evident in the pathophysiological process in most patients, so PAD has similar risk factors as coronary artery disease. Platelet-Hemoglobin ratio (PHR) has been proven to predict mortality in atherosclerotic heart disease. We aimed to determine the relationship between PHR and below-knee amputation.

METHODS

The study is a single-center retrospective study. Platelet count/hemoglobin amount formula was used for PHR. Only PAD patients with below-knee critical extremity ischemia and unsuitable for revascularization were included in the study.

RESULTS

235 patients were included in the study retrospectively. The mean age was 65.7 ± 9.9 years and 175(74.5%) of them were male. In the amputated group, white blood cell, neutrophil, platelet, creatinine, glucose, and PHR were higher (p = .031, p = .045, p = .011, p = .048 p = .018, p = .004, respectively). Only hemoglobin values were lower (p = .003). Multivariable regression analysis showed; age, albumin and PHR were determined as independent risk factors for amputation (Age; OR (95%CI): (1.094(1.040-1.152), p = .001) (Albumin; OR (95% CI): 1.950(1.623-1.799), p = .001) (PHR; OR (95% CI): 1.872(1.246-2.812), p = .003). Receiver operating characteristics analysis performed to determine the optimal cut-off value of PHR for amputation, the optimal value was found 2.08 (65.8% sensitivity, 67.5% specificity, p < .001).

CONCLUSIONS

PHR was a good predictor for BKA. Using the PHR, it may be possible to identify high-risk patients for amputation.

摘要

背景

外周动脉疾病(PAD)目前导致了大量的发病率。在大多数患者中,动脉粥样硬化在病理生理过程中很明显,因此 PAD 与冠状动脉疾病有相似的危险因素。血小板-血红蛋白比值(PHR)已被证明可预测动脉粥样硬化性心脏病的死亡率。我们旨在确定 PHR 与膝下截肢之间的关系。

方法

本研究为单中心回顾性研究。使用血小板计数/血红蛋白量公式计算 PHR。本研究仅纳入有膝下严重肢体缺血且不适合血运重建的 PAD 患者。

结果

回顾性纳入 235 例患者。平均年龄为 65.7±9.9 岁,175 例(74.5%)为男性。在截肢组中,白细胞、中性粒细胞、血小板、肌酐、葡萄糖和 PHR 较高(p=0.031,p=0.045,p=0.011,p=0.048,p=0.018,p=0.004)。只有血红蛋白值较低(p=0.003)。多变量回归分析显示;年龄、白蛋白和 PHR 是截肢的独立危险因素(年龄;OR(95%CI):(1.094(1.040-1.152),p=0.001)(白蛋白;OR(95%CI):1.950(1.623-1.799),p=0.001)(PHR;OR(95%CI):1.872(1.246-2.812),p=0.003)。为确定 PHR 对截肢的最佳截断值进行了受试者工作特征分析,发现最佳值为 2.08(65.8%敏感性,67.5%特异性,p<0.001)。

结论

PHR 是 BKA 的良好预测指标。使用 PHR 可能可以识别出高截肢风险的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc3/9336049/d3aabba9695a/12872_2022_2788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc3/9336049/e6df6d82e2fc/12872_2022_2788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc3/9336049/d3aabba9695a/12872_2022_2788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc3/9336049/e6df6d82e2fc/12872_2022_2788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc3/9336049/d3aabba9695a/12872_2022_2788_Fig2_HTML.jpg

相似文献

1
Platelet-hemoglobin ratio predicts amputation in patients with below-knee peripheral arterial disease.血小板-血红蛋白比值预测膝下外周动脉疾病患者的截肢。
BMC Cardiovasc Disord. 2022 Jul 28;22(1):337. doi: 10.1186/s12872-022-02788-2.
2
Survival after major lower extremity amputation in patients with end-stage renal disease.终末期肾病患者大肢体截肢后的生存情况。
J Vasc Surg. 2019 Oct;70(4):1291-1298. doi: 10.1016/j.jvs.2018.12.055.
3
Risk factors for wound complications and 30-day mortality after major lower limb amputations in patients with peripheral arterial disease.外周动脉疾病患者行主要下肢截肢术后伤口并发症及30天死亡率的危险因素。
Vascular. 2018 Feb;26(1):12-17. doi: 10.1177/1708538117714197. Epub 2017 Jun 6.
4
Statin use and other factors associated with mortality after major lower extremity amputation.他汀类药物的使用及与下肢大截肢术后死亡率相关的其他因素。
J Vasc Surg. 2017 Jul;66(1):216-225. doi: 10.1016/j.jvs.2017.01.048. Epub 2017 Apr 18.
5
Analysis of Patients Undergoing Major Lower Extremity Amputation in the Vascular Quality Initiative.血管质量倡议中接受下肢大截肢手术患者的分析
Ann Vasc Surg. 2018 Jan;46:75-82. doi: 10.1016/j.avsg.2017.07.034. Epub 2017 Sep 6.
6
Risk factors and indications for readmission after lower extremity amputation in the American College of Surgeons National Surgical Quality Improvement Program.美国外科医师学会国家外科质量改进计划中下肢截肢术后再入院的风险因素及指征
J Vasc Surg. 2014 Nov;60(5):1315-1324. doi: 10.1016/j.jvs.2014.05.050. Epub 2014 Jun 28.
7
Peripheral Artery Disease Leading to Major Amputation: Trends in Revascularization and Mortality Over 18 Years.外周动脉疾病导致的主要截肢:18 年来血管再通和死亡率的趋势。
Ann Vasc Surg. 2022 Jan;78:295-301. doi: 10.1016/j.avsg.2021.04.037. Epub 2021 Jun 25.
8
High hemoglobin A associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization.血红蛋白 A 水平高与外周动脉疾病患者血运重建后不良肢体事件增加相关。
J Vasc Surg. 2018 Jan;67(1):217-228.e1. doi: 10.1016/j.jvs.2017.06.101. Epub 2017 Aug 31.
9
Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes.2 型糖尿病患者下肢截肢水平与微血管和大血管疾病及肿瘤坏死因子受体 1 的关系。
Cardiovasc Diabetol. 2018 Jun 8;17(1):81. doi: 10.1186/s12933-018-0725-9.
10
The Modified Frailty Index Does Not Predict Mortality After Major Lower Extremity Amputation for Peripheral Arterial Disease in an Asian Population.改良衰弱指数不能预测亚洲人群下肢主要截肢术后外周动脉疾病的死亡率。
Ann Vasc Surg. 2020 Nov;69:298-306. doi: 10.1016/j.avsg.2020.05.063. Epub 2020 Jun 4.

引用本文的文献

1
Cholinesterase and Inflammation: Exploring Its Role and Associations with Inflammatory Markers in Patients with Lower Extremity Artery Disease.胆碱酯酶与炎症:探讨其在下肢动脉疾病患者中的作用及其与炎症标志物的关联。
Biomedicines. 2025 Mar 30;13(4):823. doi: 10.3390/biomedicines13040823.
2
Association of non-insulin-dependent insulin resistance indices with lower limb artery restenosis after drug-coated balloon angioplasty.非胰岛素依赖型胰岛素抵抗指数与药物涂层球囊血管成形术后下肢动脉再狭窄的相关性
Lipids Health Dis. 2024 Dec 18;23(1):403. doi: 10.1186/s12944-024-02394-5.
3
Evaluation of sirtuin 1 as a predictor of cardiovascular outcomes in diabetic patients with limb-threatening ischemia.

本文引用的文献

1
Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure.血小板与血红蛋白比值可作为充血性心力衰竭合并冠心病患者长期全因死亡率的有价值预测指标。
BMC Cardiovasc Disord. 2021 Dec 28;21(1):618. doi: 10.1186/s12872-021-02423-6.
2
The Impact of Anemia on One-Year Amputation-Free Survival in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia: A Retrospective Cohort Study.贫血对慢性肢体威胁性缺血患者血管重建后一年无截肢生存率的影响:一项回顾性队列研究。
Ann Vasc Surg. 2022 Feb;79:201-207. doi: 10.1016/j.avsg.2021.07.020. Epub 2021 Oct 10.
3
评估 SIRT1 作为伴有肢体威胁性缺血的糖尿病患者心血管结局的预测因子。
Sci Rep. 2024 Nov 6;14(1):26940. doi: 10.1038/s41598-024-78576-z.
4
Prognostic Value of Platelet-to-Lymphocyte Ratio Combined with CHADS-VAS Score for Nonvalvular Atrial Fibrillation Induced Cardiogenic Cerebral Embolism.血小板与淋巴细胞比值联合CHADS-VAS评分对非瓣膜性心房颤动所致心源性脑栓塞的预后价值
J Inflamm Res. 2023 Dec 6;16:5937-5947. doi: 10.2147/JIR.S431149. eCollection 2023.
5
A practical nomogram for predicting amputation rates in acute compartment syndrome patients based on clinical factors and biochemical blood markers.基于临床因素和生化血液标志物的急性间隔综合征患者截肢率预测实用列线图。
BMC Musculoskelet Disord. 2023 Aug 9;24(1):640. doi: 10.1186/s12891-023-06746-7.
6
Association of inflammation indices with left atrial thrombus in patients with valvular atrial fibrillation.炎症指标与瓣膜性心房颤动患者左心房血栓的相关性。
BMC Cardiovasc Disord. 2023 Jan 9;23(1):9. doi: 10.1186/s12872-023-03036-x.
Impact of nutritional and inflammatory status in patients with critical limb-threatening ischemia.
营养和炎症状态对严重肢体缺血患者的影响。
Int Angiol. 2021 Dec;40(6):504-511. doi: 10.23736/S0392-9590.21.04739-8. Epub 2021 Oct 12.
4
The relation between neutrophil/lymphocyte and platelet/lymphocyte ratios with mortality and limb amputation after acute limb ischaemia.急性肢体缺血后中性粒细胞/淋巴细胞及血小板/淋巴细胞比值与死亡率和肢体截肢之间的关系。
Vascular. 2022 Apr;30(2):267-275. doi: 10.1177/17085381211010012. Epub 2021 Apr 21.
5
Association between anemia and mortality in patients with acute coronary syndrome treated with percutaneous coronary intervention and contemporary lipid-lowering therapy.贫血与经皮冠状动脉介入治疗和当代降脂治疗的急性冠状动脉综合征患者死亡率的关系。
Heart Vessels. 2021 Nov;36(11):1626-1634. doi: 10.1007/s00380-021-01850-x. Epub 2021 Apr 11.
6
The role of prognostic nutritional index in predicting amputation in patients with lower extremity peripheral artery disease.预后营养指数在预测下肢外周动脉疾病患者截肢情况中的作用。
J Cardiovasc Thorac Res. 2021;13(1):43-48. doi: 10.34172/jcvtr.2021.02. Epub 2021 Jan 13.
7
Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.慢性肾脏病中的血管病变:病理生理机制和新的治疗方法。
J Mol Med (Berl). 2021 Mar;99(3):335-348. doi: 10.1007/s00109-021-02037-7. Epub 2021 Jan 22.
8
Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.靶向尿毒症毒素以预防慢性肾脏病的外周血管并发症
Toxins (Basel). 2020 Dec 20;12(12):808. doi: 10.3390/toxins12120808.
9
Association between serum albumin and peripheral arterial disease in hypertensive patients.血清白蛋白与高血压患者外周动脉疾病的关系。
J Clin Hypertens (Greenwich). 2020 Dec;22(12):2250-2257. doi: 10.1111/jch.14071. Epub 2020 Oct 9.
10
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review.冠心病和外周动脉疾病负担:文献综述。
Cardiovasc Ther. 2019 Nov 26;2019:8295054. doi: 10.1155/2019/8295054. eCollection 2019.